FDA Inspection 1084107 — Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)
The FDA completed an inspection of Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) on Mar 22, 2019 in Wenzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 22, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wenzhou (China)